Home » Stocks » CLCS

Cell Source, Inc. (CLCS)

Stock Price: $1.90 USD -0.05 (-2.56%)
Updated Jul 22, 2021 3:59 PM EDT - Market closed
Market Cap 62.06M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 32.66M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 22
Last Price $1.90
Previous Close $1.95
Change ($) -0.05
Change (%) -2.56%
Day's Open 1.90
Day's Range 1.90 - 1.93
Day's Volume 7,350
52-Week Range 0.75 - 2.55

News

There are no news available yet.

About CLCS

Cell Source, Inc., a biotechnology company, develops cell therapy treatments. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various canc... [Read more...]

Industry
Biotechnology
Founded
2011
Stock Exchange
OTCMKTS
Ticker Symbol
CLCS
Full Company Profile

Financial Performance

Financial Statements